|
REL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.183800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.36100000003303E-06 |
| Normal-vs-Stage2 |
2.618500E-02 |
| Normal-vs-Stage3 |
1.679200E-03 |
| Normal-vs-Stage4 |
1.381950E-02 |
| Stage1-vs-Stage2 |
3.362000E-01 |
| Stage1-vs-Stage3 |
7.438200E-01 |
| Stage1-vs-Stage4 |
9.487400E-01 |
| Stage2-vs-Stage3 |
6.268800E-01 |
| Stage2-vs-Stage4 |
6.505000E-01 |
| Stage3-vs-Stage4 |
9.059600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.9036999999984E-05 |
| Normal-vs-AfricanAmerican |
1.212520E-04 |
| Normal-vs-Asian |
4.69940000247249E-08 |
| Caucasian-vs-AfricanAmerican |
7.395000E-01 |
| Caucasian-vs-Asian |
1.342840E-03 |
| AfricanAmerican-vs-Asian |
6.702900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.99770000003974E-07 |
| Normal-vs-Female |
5.398200E-01 |
| Male-vs-Female |
4.791900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.60130000000014E-05 |
| Normal-vs-Extreme_Weight |
9.04050001526713E-09 |
| Normal-vs-Obese |
1.348200E-02 |
| Normal-vs-Extreme_Obese |
7.042000E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.930600E-01 |
| Normal_Weight-vs-Obese |
1.070820E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.659000E-01 |
| Extreme_Weight-vs-Obese |
1.246160E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.986400E-01 |
| Obese-vs-Extreme_Obese |
3.688200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.197900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.017620E-03 |
| Normal-vs-Age(61-80Yrs) |
7.80000000033532E-07 |
| Normal-vs-Age(81-100Yrs) |
4.95330000016558E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.478600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.481400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.276200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.097240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.518700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.866300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.38539999974918E-07 |
| Normal-VS-Type2 PRCC |
4.26959999999532E-06 |
| Normal-VS-KIRP CIMP |
8.464000E-01 |
| Normal-VS-Unclassified PRCC |
2.257200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.684800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.517240E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.040300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.335800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.465600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.330600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.61799999456969E-08 |
| Normal-vs-N1 |
3.678100E-02 |
| Normal-vs-N2 |
8.826400E-02 |
| N0-vs-N1 |
1.224960E-01 |
| N0-vs-N2 |
5.513800E-01 |
| N1-vs-N2 |
7.415200E-01 |
|
|
